— Know what they know.
Not Investment Advice
Also trades as: 0A8E.L (LSE) · $vol 0M

XERS NASDAQ

Xeris Biopharma Holdings, Inc.
1W: +0.0% 1M: +5.6% 3M: -3.5% YTD: -13.2% 1Y: +25.6% 3Y: +123.9% 5Y: +85.5%
$6.19
-0.19 (-2.98%)
 
Weekly Expected Move ±6.1%
$5 $6 $6 $7 $7
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 61 · $1.1B mcap · 161M float · 1.15% daily turnover · Short 40% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
56.3 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -60.2%
Cost Advantage
59
Intangibles
45
Switching Cost
73
Network Effect
78
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. XERS has a Narrow competitive edge (56.3/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. Negative ROIC of -60.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$14
Avg Target
$14
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 9Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$13.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-12-08 Barclays Initiated $9 +28.8% $6.99
2025-10-29 Oppenheimer Leland Gershell $5 $18 +13 +80.5% $9.97
2025-03-07 Piper Sandler $3 $4 +1 -5.7% $4.24
2024-11-11 H.C. Wainwright Oren Livnat Initiated $7 +103.4% $3.25
2024-10-23 Oppenheimer Leland Gershell Initiated $5 +65.6% $3.02
2024-05-10 Piper Sandler David Amsellem Initiated $3 +62.4% $1.85
2022-04-28 Craig-Hallum Initiated $6 +179.0% $2.33

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
1
ROE
5
ROA
4
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. XERS receives an overall rating of C+. Strongest factors: ROE (5/5), ROA (4/5). Areas of concern: DCF (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-07 C C+
2026-05-04 C- C
2026-04-30 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

54 Grade C
Profitability
31
Balance Sheet
51
Earnings Quality
63
Growth
88
Value
31
Momentum
100
Safety
15
Cash Flow
78
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. XERS scores highest in Momentum (100/100) and lowest in Safety (15/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.73
Distress Zone
Piotroski F-Score
7/9
Beneish M-Score
-2.67
Unlikely Manipulator
Ohlson O-Score
-4.84
Bankruptcy prob: 0.8%
Low Risk
Credit Rating
BB+
Score: 46.8/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 4.04x
Accruals: -10.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. XERS scores 0.73, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. XERS scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. XERS's score of -2.67 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. XERS's implied 0.8% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. XERS receives an estimated rating of BB+ (score: 46.8/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). XERS's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
87.90x
PEG
0.01x
P/S
3.39x
P/B
81.13x
P/FCF
17.96x
P/OCF
21.23x
EV/EBITDA
21.30x
EV/Revenue
3.04x
EV/EBIT
29.61x
EV/FCF
16.68x
Earnings Yield
1.17%
FCF Yield
5.57%
Shareholder Yield
1.07%
Graham Number
$0.34
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 87.9x earnings, XERS is priced for high growth expectations. Graham's intrinsic value formula yields $0.34 per share, 1708% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.372
EBT / EBIT
×
EBIT Margin
0.103
EBIT / Rev
×
Asset Turnover
0.891
Rev / Assets
×
Equity Multiplier
-44.367
Assets / Equity
=
ROE
-150.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. XERS's ROE of -150.8% is driven by Asset Turnover (0.891), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$0.57
Price/Value
10.09x
Margin of Safety
-909.39%
Premium
909.39%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with XERS's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. XERS trades at a 909% premium to its adjusted intrinsic value of $0.57, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 87.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.19
Median 1Y
$4.11
5th Pctile
$1.14
95th Pctile
$14.82
Ann. Volatility
81.9%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
John Shannon
Chief Executive Officer
$742,334 $2,848,000 $5,042,584
Kevin McCulloch
President and Chief Operating Officer
$543,833 $658,600 $2,270,973
Medical
edical Officer
$409,231 $1,128,000 $2,000,648
Anh Nguyen
$409,231 $1,128,000 $2,000,648
Beth P. Hecht
Chief Legal Officer and Corporate Secretary
$517,089 $658,600 $1,895,274
Steven M. Pieper
Chief Financial Officer
$505,393 $658,600 $1,874,090

CEO Pay Ratio

12:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,042,584
Avg Employee Cost (SGA/emp): $419,246
Employees: 435

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
435
+10.4% YoY
Revenue / Employee
$670,908
Rev: $291,845,000
Profit / Employee
$1,274
NI: $554,000
SGA / Employee
$419,246
Avg labor cost proxy
R&D / Employee
$71,644
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -3.5% -3.9% -1.9% -2.1% -2.1% -2.1% -1.3% -1.1% -1.0% -88.0% -3.2% -3.4% -3.1% -3.3% 3.0% 2.5% 1.8% 85.9% -7.0% -1.5% -1.51%
ROA -62.5% -70.0% -53.0% -59.6% -59.0% -57.2% -29.2% -24.0% -22.0% -19.0% -18.7% -19.3% -17.9% -18.9% -17.0% -14.0% -9.9% -4.8% 0.2% 3.4% 3.40%
ROIC 4.6% 5.2% -1.1% -1.2% -1.2% -1.1% -53.4% -43.1% -41.2% -32.1% -23.2% -23.7% -19.6% -23.8% -15.6% -10.4% -4.6% 4.5% -41.8% -60.2% -60.25%
ROCE -56.0% -64.0% -51.3% -57.5% -56.3% -53.6% -29.8% -22.4% -19.1% -14.5% -16.2% -16.7% -13.3% -15.8% -12.0% -7.6% -2.3% 6.3% 8.2% 11.8% 11.80%
Gross Margin 62.0% 70.8% 77.4% 71.6% 81.0% 82.3% 81.0% 84.0% 80.1% 83.0% 76.8% 85.3% 78.2% 75.0% 84.2% 85.5% 79.6% 85.2% 77.8% 84.0% 84.02%
Operating Margin -2.9% -2.2% -2.2% -1.3% -74.7% -63.2% -45.8% -40.0% -42.0% -10.2% -22.2% -35.1% -17.0% -23.8% 2.8% -5.1% 6.3% 9.0% 19.5% 9.5% 9.52%
Net Margin -3.1% -2.4% -2.3% -1.5% -1.0% -73.4% -39.0% -50.7% -52.2% -25.2% -30.2% -46.7% -31.2% -29.0% -8.5% -15.3% -2.7% 0.8% 12.9% 2.7% 2.69%
EBITDA Margin -2.9% -2.2% -2.2% -1.2% -79.1% -50.8% -16.3% -22.4% -28.0% -4.8% -7.5% -20.7% -6.5% -15.0% 9.5% 2.0% 12.0% 14.9% 16.5% 13.4% 13.38%
FCF Margin -2.2% -2.2% -1.9% -1.9% -1.5% -1.2% -93.8% -67.1% -56.6% -47.7% -30.8% -26.0% -22.1% -17.9% -18.6% -12.3% -2.7% 7.4% 12.9% 18.2% 18.22%
OCF Margin -2.1% -2.2% -1.9% -1.9% -1.5% -1.2% -93.3% -66.4% -55.0% -46.3% -29.4% -24.7% -21.5% -17.4% -18.2% -12.0% -6.6% 4.0% 9.8% 15.4% 15.41%
ROA 3Y Avg snapshot only -10.26%
ROIC Economic snapshot only 79.51%
Cash ROA snapshot only 12.65%
NOPAT Margin snapshot only 11.40%
Pretax Margin snapshot only 3.81%
R&D / Revenue snapshot only 10.23%
SGA / Revenue snapshot only 60.82%
SBC / Revenue snapshot only 5.69%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -3.22 -1.74 -2.91 -2.50 -1.53 -1.60 -1.91 -2.87 -5.04 -4.16 -5.21 -4.82 -5.60 -6.73 -9.22 -18.57 -22.76 -92.44 2551.56 85.80 87.903
P/S Ratio 8.01 4.61 7.17 5.43 2.61 2.15 1.64 1.84 2.68 1.68 1.98 1.81 1.84 2.27 2.49 3.76 2.96 5.43 4.84 3.27 3.394
P/B Ratio 8.00 4.83 3.75 3.63 2.19 2.23 4.00 4.95 7.96 5.68 -47.86 -45.79 -49.22 -62.61 -17.07 -28.26 -24.60 -48.82 103.26 75.26 81.127
P/FCF -3.72 -2.07 -3.70 -2.87 -1.72 -1.82 -1.75 -2.75 -4.74 -3.52 -6.43 -6.97 -8.34 -12.69 -13.35 -30.52 -109.75 72.93 37.42 17.96 17.959
P/OCF 136.94 49.38 21.23 21.231
EV/EBITDA -3.11 -1.41 -3.02 -2.65 -1.63 -1.78 -3.77 -6.25 -11.30 -12.91 -20.28 -18.90 -28.46 -25.20 -50.40 -238.94 125.55 61.81 38.26 21.30 21.302
EV/Revenue 6.62 3.29 6.89 5.20 2.43 2.00 2.33 2.47 3.25 2.18 2.94 2.73 2.70 3.10 3.47 4.66 3.77 6.18 4.59 3.04 3.039
EV/EBIT -3.05 -1.39 -2.97 -2.56 -1.53 -1.64 -3.18 -4.93 -8.43 -8.49 -13.05 -12.32 -16.23 -16.23 -26.49 -61.37 -179.50 117.60 59.61 29.61 29.613
EV/FCF -3.07 -1.48 -3.55 -2.75 -1.60 -1.70 -2.49 -3.68 -5.75 -4.57 -9.54 -10.49 -12.26 -17.38 -18.63 -37.80 -139.85 83.01 35.48 16.68 16.681
Earnings Yield -31.0% -57.6% -34.3% -39.9% -65.5% -62.5% -52.3% -34.8% -19.9% -24.1% -19.2% -20.7% -17.8% -14.9% -10.8% -5.4% -4.4% -1.1% 0.0% 1.2% 1.17%
FCF Yield -26.9% -48.3% -27.0% -34.9% -58.1% -54.8% -57.2% -36.4% -21.1% -28.4% -15.5% -14.3% -12.0% -7.9% -7.5% -3.3% -0.9% 1.4% 2.7% 5.6% 5.57%
PEG Ratio snapshot only 0.008
EV/OCF snapshot only 19.721
EV/Gross Profit snapshot only 3.725
Acquirers Multiple snapshot only 26.655
Shareholder Yield snapshot only 1.07%
Graham Number snapshot only $0.34
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 5.40 5.40 1.80 1.80 1.80 1.80 2.54 2.54 2.54 2.54 1.64 1.64 1.64 1.64 1.67 1.67 1.67 1.67 2.19 2.19 2.193
Quick Ratio 5.10 5.10 1.57 1.57 1.57 1.57 2.20 2.20 2.20 2.20 1.23 1.23 1.23 1.23 1.19 1.19 1.19 1.19 1.57 1.57 1.566
Debt/Equity 2.58 2.58 0.92 0.92 0.92 0.92 4.38 4.38 4.38 4.38 -33.79 -33.79 -33.79 -33.79 -9.17 -9.17 -9.17 -9.17 2.76 2.76 2.759
Net Debt/Equity -1.39 -1.39 -0.15 -0.15 -0.15 -0.15 1.68 1.68 1.68 1.68 -5.35 -5.35 -5.353
Debt/Assets 0.55 0.55 0.29 0.29 0.29 0.29 0.57 0.57 0.57 0.57 0.71 0.71 0.71 0.71 0.84 0.84 0.84 0.84 0.10 0.10 0.098
Debt/EBITDA -1.21 -1.06 -0.77 -0.70 -0.74 -0.79 -2.91 -4.13 -5.13 -7.68 -9.66 -9.27 -13.30 -9.94 -19.40 -62.56 36.72 10.20 1.08 0.84 0.841
Net Debt/EBITDA 0.65 0.57 0.13 0.11 0.12 0.13 -1.12 -1.59 -1.97 -2.95 -6.60 -6.34 -9.09 -6.80 -14.28 -46.05 27.03 7.51 -2.09 -1.63 -1.631
Interest Coverage -6.98 -8.40 -16.09 -14.54 -12.01 -9.48 -5.27 -3.37 -2.45 -1.64 -1.39 -1.38 -1.05 -1.20 -0.87 -0.55 -0.17 0.47 0.77 1.13 1.127
Equity Multiplier 4.71 4.71 3.20 3.20 3.20 3.20 7.62 7.62 7.62 7.62 -47.57 -47.57 -47.57 -47.57 -10.91 -10.91 -10.91 -10.91 28.02 28.02 28.017
Cash Ratio snapshot only 1.013
Debt Service Coverage snapshot only 1.567
Cash to Debt snapshot only 2.940
FCF to Debt snapshot only 1.519
Defensive Interval snapshot only 267.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.25 0.26 0.21 0.27 0.35 0.43 0.34 0.37 0.41 0.47 0.49 0.51 0.54 0.56 0.63 0.69 0.76 0.82 0.83 0.89 0.891
Inventory Turnover 2.17 2.25 1.01 1.34 1.45 1.60 1.06 1.01 1.14 1.28 0.99 1.01 1.10 1.27 0.91 0.97 1.07 1.01 0.91 0.99 0.992
Receivables Turnover 5.83 6.10 4.09 5.23 6.58 8.12 4.57 5.03 5.55 6.32 4.68 4.89 5.18 5.35 5.10 5.59 6.18 6.69 6.38 6.88 6.885
Payables Turnover 2.63 2.71 2.21 2.95 3.19 3.53 3.35 3.20 3.61 4.05 3.88 3.96 4.32 4.99 5.71 6.11 6.70 6.32 19.91 21.61 21.606
DSO 63 60 89 70 55 45 80 73 66 58 78 75 70 68 72 65 59 55 57 53 53.0 days
DIO 168 162 363 272 252 228 346 361 320 286 370 362 332 288 402 375 342 362 399 368 367.9 days
DPO 139 134 165 124 114 103 109 114 101 90 94 92 84 73 64 60 54 58 18 17 16.9 days
Cash Conversion Cycle 91 88 287 218 193 169 316 319 285 253 354 345 318 283 409 381 347 359 438 404 404.0 days
Fixed Asset Turnover snapshot only 11.637
Operating Cycle snapshot only 420.9 days
Cash Velocity snapshot only 2.835
Capital Intensity snapshot only 1.218
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 4.6% 1.3% 1.4% 1.4% 1.4% 1.8% 1.2% 90.6% 67.4% 54.6% 48.7% 41.2% 35.3% 22.7% 23.9% 29.9% 35.6% 42.0% 43.7% 41.5% 41.47%
Net Income 29.7% 8.4% -34.7% -71.7% -63.2% -41.3% 22.9% 43.6% 47.7% 53.4% 34.2% 17.2% 16.6% -2.1% 11.9% 30.0% 46.3% 75.2% 1.0% 1.3% 1.27%
EPS 59.8% 36.4% 40.9% 22.1% 20.1% 30.9% 30.8% 44.5% 48.4% 54.1% 35.3% 19.2% 22.8% 5.4% 18.4% 35.5% 48.9% 79.2% 1.0% 1.2% 1.23%
FCF 36.0% 21.1% -19.4% -58.0% -66.8% -47.8% -7.0% 32.5% 37.4% 37.3% 51.2% 45.2% 47.2% 54.1% 25.0% 38.5% 83.4% 1.6% 2.0% 3.1% 3.09%
EBITDA 34.5% 12.3% -43.7% -83.6% -66.5% -34.5% 40.1% 61.6% 67.7% 76.7% 65.1% 48.4% 55.3% 10.5% 41.0% 82.5% 1.4% 2.2% 3.5% 11.4% 11.35%
Op. Income 33.3% 11.1% -37.8% -77.0% -59.5% -33.4% 28.8% 48.1% 47.6% 57.1% 46.3% 32.0% 41.2% 8.5% 23.5% 50.0% 73.6% 1.2% 1.7% 2.6% 2.60%
OCF Growth snapshot only 2.82%
Asset Growth snapshot only 18.72%
Debt Growth snapshot only -86.09%
Shares Change snapshot only 16.52%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 2.5% 1.9% 1.8% 2.0% 2.4% 2.9% 2.4% 2.0% 1.8% 1.2% 1.0% 85.5% 75.2% 74.4% 59.8% 51.8% 45.4% 39.2% 38.3% 37.4% 37.40%
Revenue 5Y 1.8% 1.6% 1.4% 1.3% 1.5% 1.6% 1.4% 1.2% 1.1% 77.4% 70.2% 63.6% 63.63%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 2.0% 1.6% 1.6% 1.7% 2.2% 2.6% 3.3% 3.9% 3.4% 1.5% 1.3% 99.8% 87.3% 84.3% 64.9% 57.7% 48.6% 42.1% 39.6% 37.1% 37.10%
Gross Profit 5Y 1.7% 1.5% 1.3% 1.3% 1.4% 1.5% 1.7% 1.9% 1.7% 96.4% 84.7% 71.2% 71.18%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 52.4% 52.4% 36.4% 36.4% 36.4% 36.4% 46.8% 46.8% 46.8% 46.8% 26.6% 26.6% 26.6% 26.6% 2.0% 2.0% 2.0% 2.0% 3.6% 3.6% 3.64%
Assets 5Y 50.2% 50.2% 21.9% 21.9% 21.9% 21.9% 24.3% 24.3% 24.3% 24.3% 19.2% 19.2% 19.23%
Equity 3Y 8.1% 8.1% 8.1% 8.1% 46.3% 46.3% 46.3% 46.3% -32.8% -32.8% -32.84%
Book Value 3Y -40.1% -39.6% -37.0% -37.0% -14.7% -9.2% -4.7% 1.5% -38.8% -38.4% -38.39%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.73 0.87 0.86 0.87 0.88 0.88 0.93 0.96 0.82 0.83 0.87 0.91 0.94 0.95 0.97 0.98 0.99 0.98 0.98 0.98 0.979
Earnings Stability 0.45 0.40 0.46 0.32 0.62 0.58 0.21 0.01 0.22 0.10 0.00 0.06 0.24 0.40 0.72 0.59 0.63 0.62 0.76 0.67 0.674
Margin Stability 0.49 0.70 0.63 0.49 0.51 0.74 0.71 0.54 0.58 0.75 0.80 0.84 0.86 0.87 0.76 0.60 0.62 0.82 0.84 0.91 0.906
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.88 0.97 0.86 0.50 0.50 0.83 0.91 0.83 0.81 0.50 0.86 0.93 0.93 0.99 0.95 0.88 0.81 0.50 0.20 0.20 0.200
Earnings Smoothness
ROE Trend 2.28 1.52 4.41 4.23 3.93 3.54 -0.10 0.19 0.38 0.72
Gross Margin Trend 0.07 -0.06 0.26 0.29 0.32 0.20 0.16 0.14 0.11 0.10 0.05 0.04 0.02 -0.02 0.00 -0.01 -0.00 0.03 0.01 0.00 0.004
FCF Margin Trend 27.80 28.91 19.18 12.69 9.03 3.23 2.01 1.70 1.27 1.22 1.13 1.02 0.82 0.65 0.44 0.34 0.37 0.40 0.38 0.37 0.374
Sustainable Growth Rate
Internal Growth Rate 0.2% 3.5% 3.52%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.86 0.83 0.78 0.87 0.88 0.87 1.09 1.04 1.03 1.14 0.77 0.66 0.65 0.52 0.67 0.59 0.51 -0.68 51.67 4.04 4.041
FCF/OCF 1.01 1.02 1.01 1.01 1.01 1.00 1.00 1.01 1.03 1.03 1.05 1.05 1.03 1.02 1.02 1.03 0.41 1.88 1.32 1.18 1.182
FCF/Net Income snapshot only 4.777
OCF/EBITDA snapshot only 1.080
CapEx/Revenue 2.5% 3.3% 2.2% 1.0% 0.8% 0.5% 0.5% 0.6% 1.6% 1.5% 1.4% 1.3% 0.6% 0.4% 0.4% 0.3% 0.1% 0.2% 0.2% 0.3% 0.32%
CapEx/Depreciation snapshot only 0.080
Accruals Ratio -0.09 -0.12 -0.12 -0.08 -0.07 -0.07 0.03 0.01 0.01 0.03 -0.04 -0.07 -0.06 -0.09 -0.06 -0.06 -0.05 -0.08 -0.08 -0.10 -0.103
Sloan Accruals snapshot only 0.144
Cash Flow Adequacy snapshot only 48.142
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 3.6% 91.9% 91.91%
Div. Increase Streak
Chowder Number
Buyback Yield 0.1% 0.2% 0.1% 0.2% 0.3% 0.3% 0.3% 0.4% 0.3% 0.4% 0.3% 1.2% 1.1% 0.9% 0.7% 1.0% 0.0% 0.0% 0.1% 1.1% 1.07%
Net Buyback Yield -11.1% -16.6% -7.5% -8.6% -14.1% -13.9% -16.3% 0.4% 0.3% 0.4% 0.3% 1.2% 1.1% 0.9% 0.7% 1.0% 0.0% -0.9% -0.3% -0.3% -0.35%
Total Shareholder Return -11.1% -16.6% -7.5% -8.6% -14.1% -13.9% -16.3% 0.4% 0.3% 0.4% 0.3% 1.2% 1.1% 0.9% 0.7% 1.0% 0.0% -0.9% -0.3% -0.3% -0.35%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.99 0.98 0.98 0.98 0.99 1.01 0.96 0.96 0.95 0.91 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.14 1.12 1.06 1.07 1.08 1.11 1.19 1.30 1.41 1.61 1.72 1.72 1.95 1.83 2.15 2.82 6.83 -1.12 0.02 0.37 0.372
EBIT Margin -2.17 -2.37 -2.32 -2.03 -1.58 -1.22 -0.73 -0.50 -0.39 -0.26 -0.23 -0.22 -0.17 -0.19 -0.13 -0.08 -0.02 0.05 0.08 0.10 0.103
Asset Turnover 0.25 0.26 0.21 0.27 0.35 0.43 0.34 0.37 0.41 0.47 0.49 0.51 0.54 0.56 0.63 0.69 0.76 0.82 0.83 0.89 0.891
Equity Multiplier 5.56 5.56 3.59 3.59 3.59 3.59 4.62 4.62 4.62 4.62 17.37 17.37 17.37 17.37 -17.74 -17.74 -17.74 -17.74 -44.37 -44.37 -44.367
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.26 $-1.41 $-1.01 $-1.02 $-1.01 $-0.97 $-0.70 $-0.57 $-0.52 $-0.45 $-0.45 $-0.46 $-0.40 $-0.42 $-0.37 $-0.30 $-0.21 $-0.09 $0.00 $0.07 $0.07
Book Value/Share $0.51 $0.51 $0.78 $0.71 $0.70 $0.70 $0.33 $0.33 $0.33 $0.33 $-0.05 $-0.05 $-0.05 $-0.05 $-0.20 $-0.19 $-0.19 $-0.17 $0.08 $0.08 $0.08
Tangible Book/Share $0.51 $0.51 $-0.48 $-0.44 $-0.44 $-0.43 $-0.72 $-0.72 $-0.72 $-0.71 $-1.01 $-0.99 $-0.94 $-0.94 $-1.02 $-0.99 $-0.97 $-0.85 $-0.54 $-0.55 $-0.55
Revenue/Share $0.51 $0.53 $0.41 $0.47 $0.59 $0.73 $0.81 $0.88 $0.98 $1.11 $1.19 $1.22 $1.22 $1.26 $1.36 $1.46 $1.58 $1.50 $1.62 $1.77 $1.85
FCF/Share $-1.10 $-1.18 $-0.79 $-0.89 $-0.89 $-0.85 $-0.76 $-0.59 $-0.55 $-0.53 $-0.37 $-0.32 $-0.27 $-0.22 $-0.25 $-0.18 $-0.04 $0.11 $0.21 $0.32 $0.28
OCF/Share $-1.08 $-1.16 $-0.78 $-0.89 $-0.89 $-0.85 $-0.76 $-0.59 $-0.54 $-0.51 $-0.35 $-0.30 $-0.26 $-0.22 $-0.25 $-0.18 $-0.10 $0.06 $0.16 $0.27 $0.28
Cash/Share $2.02 $2.01 $0.84 $0.76 $0.76 $0.75 $0.90 $0.89 $0.89 $0.88 $0.52 $0.52 $0.49 $0.49 $0.48 $0.47 $0.46 $0.40 $0.62 $0.63 $0.66
EBITDA/Share $-1.08 $-1.24 $-0.93 $-0.93 $-0.88 $-0.81 $-0.50 $-0.35 $-0.28 $-0.19 $-0.17 $-0.18 $-0.12 $-0.15 $-0.09 $-0.03 $0.05 $0.15 $0.19 $0.25 $0.25
Debt/Share $1.31 $1.31 $0.72 $0.65 $0.65 $0.65 $1.46 $1.44 $1.44 $1.43 $1.66 $1.63 $1.54 $1.54 $1.82 $1.78 $1.74 $1.53 $0.21 $0.21 $0.21
Net Debt/Share $-0.70 $-0.70 $-0.12 $-0.11 $-0.11 $-0.11 $0.56 $0.55 $0.55 $0.55 $1.13 $1.12 $1.06 $1.05 $1.34 $1.31 $1.28 $1.13 $-0.41 $-0.41 $-0.41
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.729
Altman Z-Prime snapshot only 0.021
Piotroski F-Score 6 6 5 3 4 5 5 5 4 5 3 4 3 2 6 6 6 7 7 7 7
Beneish M-Score -0.82 -2.94 139.60 139.81 139.80 139.75 -1.70 -1.87 -1.82 -1.69 -2.39 -2.59 -2.52 -2.67 -2.68 -2.59 -2.55 -2.81 -2.52 -2.67 -2.674
Ohlson O-Score snapshot only -4.838
Net-Net WC snapshot only $-0.73
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB+
Credit Score 23.72 23.97 24.09 24.41 24.60 24.95 22.99 23.03 22.87 23.19 20.00 20.00 20.00 20.00 20.00 20.00 12.72 20.00 45.13 46.76 46.759
Credit Grade snapshot only 11
Credit Trend snapshot only 26.759
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 44
Sector Credit Rank snapshot only 40

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms